EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Progress in Anti‐Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation

Lan Yao, Xiang Zhu, Yunyi Shan, Liang Zhang, Jing Yao, Hui Xiong iD

Small · 2024-06 · 20 (25)

DOI: 10.1002/smll.202310018 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 25.01.2024. Verfasst von Lan Yao und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, Department of Pharmaceutics, China Pharma…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Oxidation-Reduction, Antineoplastic Agents. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 254 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growth state of tumor cells is strictly affected by the specific abnormal redox status of the tumor microenvironment (TME). Moreover, redox reactions at the biological level are also central and fundamental to essential energy metabolism reactions in tumors. Accordingly, anti‐tumor nanodrugs targeting the disruption of this abnormal redox homeostasis have become one of the hot spots in the field of nanodrugs research due to the effectiveness of TME modulation and anti‐tumor efficiency mediated by redox interference. This review discusses the latest research results of nanodrugs in anti‐tumor therapy, which regulate the levels of oxidants or reductants in TME through a variety of therapeutic strategies, ultimately breaking the original “stable” redox state of the TME and promoting tumor cell death. With the gradual deepening of study on the redox state of TME and the vigorous development of nanomaterials, it is expected that more anti‐tumor nano drugs based on tumor redox microenvironment regulation will be designed and even applied clinically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentOxidation-ReductionAntineoplastic AgentsHumansAnimalsNeoplasmsNanoparticles

Stichwörter der Autor:innen

nanodrugsreactive oxygen levelsredoxtumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, P. R. China.

ORCID-Profile: Hui Xiong

Zitieren

APA

Yao, L., Zhu, X., Shan, Y., Zhang, L., Yao, J., & Xiong, H. (2024). Recent Progress in Anti‐Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation. Small, 20(25). https://doi.org/10.1002/smll.202310018

Vancouver

Yao L, Zhu X, Shan Y, Zhang L, Yao J, Xiong H. Recent Progress in Anti‐Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation. Small. 2024;20(25). doi:10.1002/smll.202310018

BibTeX
@article{Yao2024,
  author = {Yao, Lan and Zhu, Xiang and Shan, Yunyi and Zhang, Liang and Yao, Jing and Xiong, Hui},
  title = {Recent Progress in Anti‐Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation},
  journal = {Small},
  year = {2024},
  volume = {20},
  number = {25},
  doi = {10.1002/smll.202310018}
}
Kostenlos starten →